7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Bone Neoplasms D001859 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Calcinosis D002114 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Jaw Diseases D007571 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Biliary Atresia D001656 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Tinnitus D014012 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Measles D008457 3 associated lipids
Malocclusion D008310 3 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Addison Disease D000224 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Hirsutism D006628 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Hearing Loss D034381 3 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Tooth Migration D014085 2 associated lipids
Dengue D003715 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kong YY et al. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. 2000 Immunol. Today pmid:11071528
Sakuma Y et al. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. 2000 Infect. Immun. pmid:11083800
Riggs BL The mechanisms of estrogen regulation of bone resorption. 2000 J. Clin. Invest. pmid:11086020
Lee ZH et al. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. 2000 Mol. Pharmacol. pmid:11093794
Takami M et al. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. 2000 Endocrinology pmid:11108286
Gori F et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. 2000 Endocrinology pmid:11108292
Miyamoto T et al. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. 2000 Blood pmid:11110710
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. 2000 Bone pmid:11113385
Takayanagi H et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. 2000 Nature pmid:11117749
Mancini L et al. Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. 2000 Biochem. Biophys. Res. Commun. pmid:11118297

Table of Content